According to a recent LinkedIn post from Colossal Biosciences, the company is highlighting the biological basis of its avian de-extinction strategy using chickens as hosts for genetic material. The post explains that, because birds cannot currently be cloned, Colossal relies on primordial germ cells (PGCs) that develop into sperm and eggs to transmit edited genetic information.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
By describing how edited PGCs can be injected into a chicken embryo to carry the genetic blueprint of an extinct bird such as the dodo, the post underscores a key technical pillar of Colossal’s platform. For investors, this suggests progress in articulating a scalable approach to de-extinction and conservation genetics, potentially reinforcing the company’s positioning in synthetic biology and attracting interest from partners focused on advanced reproductive and genomic technologies.